Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM+ Hepatocellular Carcinoma

Autor: Katie Powell, Naoki Oishi, Ji Luo, Xiaoling Luo, Sean P. Martin, Hien Dang, Xiaolin Wu, Snorri S. Thorgeirsson, Qing-Hai Ye, Hu-Liang Jia, Dana A. Dominguez, Xin Wei Wang, Gary Mitchell, Rachel Bagni, Jin-Qiu Chen, Atsushi Takai, Subreen A. Khatib, Lun-Xiu Qin
Rok vydání: 2019
Předmět:
Zdroj: Cancer Research. 79:2379-2391
ISSN: 1538-7445
0008-5472
DOI: 10.1158/0008-5472.can-18-3015
Popis: Hepatocellular carcinoma (HCC) is a genetically heterogeneous disease for which a dominant actionable molecular driver has not been identified. Patients with the stem cell–like EpCAM+AFP+ HCC subtype have poor prognosis. Here, we performed a genome-wide RNAi screen to identify genes with a synthetic lethal interaction with EpCAM as a potential therapeutic target for the EpCAM+AFP+ HCC subtype. We identified 26 candidate genes linked to EpCAM/Wnt/β-catenin signaling and HCC cell growth. We further characterized the top candidate PMPCB, which plays a role in mitochondrial protein processing, as a bona fide target for EpCAM+ HCC. PMPCB blockage suppressed EpCAM expression and Wnt/β-catenin signaling via mitochondria-related reactive oxygen species production and FOXO activities, resulting in apoptosis and tumor suppression. These results indicate that a synthetic lethality screen is a viable strategy to identify actionable drivers of HCC and identify PMPCB as a therapeutically vulnerable gene in EpCAM+ HCC subpopulations. Significance: This study identifies PMPCB as critical to mitochondrial homeostasis and a synthetic lethal candidate that selectively kills highly resistant EpCAM+ HCC tumors by inactivating the Wnt/β-catenin signaling pathway.
Databáze: OpenAIRE